➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
McKesson
Dow
McKinsey
Harvard Business School

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Pimozide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for pimozide and what is the scope of freedom to operate?

Pimozide is the generic ingredient in two branded drugs marketed by Teva and Par Pharm, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for pimozide. One supplier is listed for this compound.

Drug Prices for pimozide

See drug prices for pimozide

Recent Clinical Trials for pimozide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rambam Health Care CampusEarly Phase 1
Rabin Medical CenterEarly Phase 1
ALS CanadaPhase 2

See all pimozide clinical trials

Pharmacology for pimozide
Medical Subject Heading (MeSH) Categories for pimozide
Anatomical Therapeutic Chemical (ATC) Classes for pimozide

US Patents and Regulatory Information for pimozide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva ORAP pimozide TABLET;ORAL 017473-001 Jul 31, 1984 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Par Pharm PIMOZIDE pimozide TABLET;ORAL 204521-001 Sep 28, 2015 RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Par Pharm PIMOZIDE pimozide TABLET;ORAL 204521-002 Sep 28, 2015 RX No Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva ORAP pimozide TABLET;ORAL 017473-003 Aug 27, 1997 DISCN Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
McKesson
Dow
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.